Neonatal Epileptic Encephalopathy
Lancet 361:1614, Clayton,P.T.,et al, 2003
Proton MR Spectroscopy in Wernicke Encephalopathy
AJNR 24:952-955, Rugilo,C.A.,et al, 2003
Pernicious Anemia with Neuropsychiatric Dysfunction in a Patient with Sickle Cell Anemia Treated with Folate Supplementation
NEJM 348:2204-2207, Dhar,M.,et al, 2003
Mental Illness in New Neurological Patients
JNNP 74:817-819, Fink,P.,et al, 2003
Clinical Spectrum of Succinic Semialdehyde Dehydrogenase Deficiency
Neurol 60:1413-1417, Pearl,P.L.,et al, 2003
Neurotoxicity Following Addition of Intravenous Valproate to Lamotrigine Therapy
Neurol 60:1991-1992, Burneo,J.G.,et al, 2003
A 48-Year-Old Man With Temporal Lobe Epilepsy and Psychiatric Illness
JAMA 290:381-392, Devinsky,O., 2003
Clinical Manifestations of Sarin Nerve Gas Exposure
JAMA 290:659-662, Lee,E.C., 2003
Treatment of Primary CNS Lymphoma with Methotrexate and Deferred Radiotherapy: A Report of NABTT 96-07
J Clin Oncol 21:1044-1049, Batchelor,T.,et al, 2003
Biochemical And Clinical Aspects of Methotrexate Neurotoxicity
Chemotherapy 49:92-104, Vezmar,S.,et al, 2003
Acute Carbon Monoxide Poisoning: Diffusion MR Imaging Findings
AJNR 24;1475-1477, Sener,R.N., 2003
Learning Disability
Lancet 362:811-821, Gillberg,C.&Soderstrom,H., 2003
Clinical Features and Neuropathology of Autosomal Dominant Spinocerebellar Ataxia (SCA17)
Ann Neurol 43:367-375, Rolfs,A.,et al, 2003
MR Imaging and Diffusion-Weighted Imaging Changes in Metronidazole (Flagyl)-Induced Cerebellar Toxicity
AJNR 24:1615-1617, Heaney,C.J.,et al, 2003
A Multicenter Study of Treatment of Primary CNS Lymphoma
Neurol 58:1513-1520, Ferreri,A.J.M.,et al, 2002
First-line Therapy with Temozolomide Induces Regression of Primary CNS Lymphoma
Neurol 58:1573-1574, Herrlinger,U.,et al, 2002
Reversible Metronidazole-Induced Lesions of the Cerebellar Dentate Nuclei
NEJM 346:68-69, Woodruff,B.K.,et al, 2002
Recombinant Interferon-a-induced Chorea and Frontal Subcortical Dementia
Neurol 58:328-330, Moulignier,A.,et al, 2002
Diffusion-Weighted Imaging Abnormalities in Wernicke Encephalopathy
Arch Neurol 59:123-127, Chu,K.,et al, 2002
Neuropsychiatry of the Basal Ganglia
JNNP 72:12-21, Ring,H.A &Serra-Mestres,J., 2002
Diffusion Abnormalities in Patients with Wernicke Encephalopathy
Neurol 58:655-657, Doherty, M.J.,et al, 2002
The Neurological Masquerade of Intravascular Lymphomatosis
Arch Neurol 59:439-443, Beristain,X.&Azzarelli,B., 2002
Thalidomide-Induced Neuropathy
Neurol 59:1872-1875, Chaudhry,V.,et al, 2002
Prevalence of Neuropsychiatric Symptoms in Dementia and Mild Cognitive Impairment
JAMA 288:1475-1483, Lyketsos,C.G.,et al, 2002
A Woman who Gained Weight and Became Schizophrenic
Lancet 360:1392, Zielasek,J.,et al, 2002
Proton MR Spectroscopy of Wernicke Encephalopathy
AJNR 23:1803-1806, Mascalchi,M.,et al, 2002
Severe Neurologic Complications After Hematopoietic Stem Cell Transplantation in Children
Neurol 59:1895-1904,E13, Farci,M.,et al, 2002
Paraneoplastic Chorea Associated with CRMP-5 Neuronal Antibody and Lung Carcinoma
Ann Neurol 51:625-630, Vernino,S.,et al, 2002
Functional Brain Mapping of Psychopathology
JNNP 72:432-439, Honey,G.D.,et al, 2002
Wernicke's Encephalopathy in a Woman on Slimming Diet
Neurol 58:1697-1698, Sechi,G.P.,et al, 2002
Nanging
Lancet 360:384, Ng, J. &Frith, R., 2002
AAC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins
Stroke 33:2337-2341, Pasternak,R.C.,et al, 2002
Gliomatosis Cerebri: Molecular Pathology and Clinical Course
Ann Neurol 52:390-399,389, Herrlinger,U.,et al, 2002
Delayed Neuropathy and Myelopathy After Organophosphate Intoxication
NEJM 347:1119-1121, Chuang,C.,et al, 2002
Brain Metastases from Bladder Carcinoma: Presentation, Treatment and Survival
, Mahmoud-Ahmed, A.S.,et al, 2002
Neurological Complications of Coeliac Disease
Postgrad Med J 78:393-398, Tengah, D.S.N.A.,et al, 2002
Acute Hepatic Encephalopathy with Diffuse Cortical Lesions
Neuroradiology 43:551-554, Arnold, S.M.,et al, 2001
Gemcitabine-Associated Posterior Reversible Encephalopathy Syndrome: MR Imaging and MR Spectroscopy Findings
Magnetic Resonance Imaging 19:129-132, Russell,M.T,et al, 2001
Schizophrenia in a Patient with Cerebral Autosomally Dominant Arteriopathy with Subcortical Infarcts and Leucoencephalopathy (CADASIL Disease)
Nord J Psychiatry 55:41-42, Lagas,P.A. &Juvonen,V., 2001
Safety of HMG-CoA Reductase Inhibitors: Focus on Atorvastatin
Cardiovasc Drugs Ther 15:211-218, Bernini,F.,et al, 2001
Cerebral Sinus Thrombosis with Tamoxifen
Neurol 56:1113-1114, Finelli,P.F. & Schauer,P.K., 2001
Adverse Long-term Effects of Brain Radiotherapy in Adult Low-grade Glioma Patients
Neurol 56:1285-1290,1255, Surma-aho,O.,et al, 2001
Treatment of Brain Metastases of Malignant Melanoma with Temozolomide
NEJM 345:621-622, Biasco,G.,et al, 2001
Primary Central Nervous System T-Cell Lymphoma
Neurol 57:716-718, Gijtenbeek,J.M.M.,et al, 2001
The Neurologic Complications of Scleromyxedema
Medicine 80:313-319, Berger,J.R.,et al, 2001
Quantifying Radiation Therapy-induced Brain Injury with Whole-Brain Proton MR Spectroscopy: Initial Observations
Radiology 221:327-331, Movsas,B.,et al, 2001
Neurology of Ciguatera
JNNP 70:4-8, Pearn,J., 2001
Welding-Related Parkinsonism
Neurol 56:8-13,4, Racette,B.A.,et al, 2001
Reversible Posterior Leukoencephalopathy During the Treatment of Acute Lymphoblastic Leukemia
Neurol 56:388-391, Shin,R.K.,et al, 2001
Botulinum Toxin as a Biological Weapon
JAMA 285:1059-1070, Arnon,S.S.,et al, 2001